Skip to content

Analytical chemistry plays a crucial role in characterizing and understanding materials produced through nanoforming. We use a variety of techniques to analyze our nanoparticles and formulations with state-of-the-art equipment and software to accurately measure nanoparticles properties, such as purity, size, shape and crystallinity. This information is both essential for understanding how to develop our formulations and predict how drugs will perform in vivo, and in generating unique IP positions for drug products.

The solid-state properties of our nanoparticles are also a key area of focus for our team. By carefully manipulating these properties, we can control solubility, stability, and bioavailability.

Nanoparticle characterization is a critical aspect of our pharmaceutical development.

Read
our article

Enabling Subcutaneous Delivery for Improved Patient Compliance & Healthcare System Efficiencies

DLS Malvern Pananalytical Zetasizer Ultra DLS
LDA Malvern Pananalytical Mastersizer 3000
SEM ZEISS GeminiSEM, Hitachi Regulus and COXEM EM Series systems
XRPD Malvern Pananalytical Empyrean Series 3
TGA TA Instruments TGA 550
DSC TA Instruments DSC 250
UPLC and HPLC Waters™ Acquity and Agilent 1290 Infinity III systems
AFM Park Systems NX10
Karl-Fischer Mettler Toledo C30
FTIR PerkinElmer Spectrum™ III
POM Nikon microscope
SDS-page Bio-Rad equipment with ChemiDoc™ imaging system
Western blot imager Bio-Rad Trans-Blot Turbo Transfer System

R&D and GMP laboratories are filled by highly qualified personnel with in-depth understanding of how material characteristics enable prediction of in vitro characteristics and in vivo performance. In addition, nanoparticle and nanoformulation stability data can be generated at ICH guided accelerated and room temperature conditions, and at 2-8 °C, -20 °C and -80 °C.

Get in touch to find out how our CESS® technology can help your small-molecule drugs reach their full therapeutic potential